Cadrenal Therapeutics, Inc. Share Price
CVKDCadrenal Therapeutics, Inc. Stock Performance
Open $7.06 | Prev. Close $7.02 | Circuit Range N/A |
Day Range $7.02 - $7.06 | Year Range $7.02 - $21.45 | Volume 316 |
Average Traded $7.04 |
Cadrenal Therapeutics, Inc. Share Price Chart
About Cadrenal Therapeutics, Inc.
Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company focuses on developing therapeutics for rare cardiovascular conditions. The company is developing Tecarfarin, a novel oral and reversible anticoagulant to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation, such as patients with left ventricular assist devices, end-stage kidney disease, atrial fibrillation, and thrombotic anti-phospholipid syndrome. It has a collaboration agreement with Abbott Global Enterprises Limited to evaluate the efficacy and safety of Tecarfarin in patients with a left-ventricular assist device. Cadrenal Therapeutics, Inc. was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.
Cadrenal Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
29-Dec-25 | $7.06 | $7.02 | +0.00% |
29-Dec-25 | $7.06 | $7.02 | -5.14% |
26-Dec-25 | $7.25 | $7.40 | +2.35% |
24-Dec-25 | $7.23 | $7.23 | +0.00% |
23-Dec-25 | $7.65 | $7.23 | -1.36% |
22-Dec-25 | $7.29 | $7.33 | +2.95% |
19-Dec-25 | $7.21 | $7.12 | -4.04% |
FAQs on Cadrenal Therapeutics, Inc. Share Price
Can I buy Cadrenal Therapeutics, Inc. shares in India?
What is the share price of Cadrenal Therapeutics, Inc.?
What is the 5 year returns of Cadrenal Therapeutics, Inc.?
What are the high & low stock price of Cadrenal Therapeutics, Inc. today?
What is the 52-week high and low of Cadrenal Therapeutics, Inc. stock?